1047P Tocilizumab is an effective secondary prophylaxis during immune checkpoint inhibitor rechallenge following arthritis
| Autor: | Obeid, M., Petit, P-F., Latifyan, S., Daoudlarian, D., Joo, V., Bartolini, R., Bouchaab, H., Mederos Alfonso, N., Abdelhamid, K., Doms, J., Ferahta, N., Mencarelli, L., Stravodimou, A., Shabafrouz, K., Pantaleo, G., Peters, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S699-S700 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|